Medical Device & Pharmaceutical Regulatory Consulting in Australia | GRP

Committed to your success, from Concept to Approval.

Medical Device and Pharmaceuticals Regulatory Affairs and Quality Consulting for Australia

Australia Regulatory Affairs

GRP provides Regulatory, Clinical and Compliance services across the globe

North America
Latin America
European Union

Choose the Country

Learn more about how we can assist you with Regulatory, Clinical and Compliance services in your country of interest


Australia, with 22 million residents, is the third-largest device market in the Asia Pacific region – after Japan and China.

Australia Medical Device Market Size Australia Pharmaceutical Market Size
$11.8 billion $22.7 billion
 Projected Growth Rate: 6% Projected Growth Rate: 5.1%


Australia Economic Indicators
GDP (PPP): $1.56 trillion
Per Capita GDP (PPP): $42,450
Real GDP Growth Rate: 2.5%
Population (millions): 23.13
Ethnic Diversity:  English 25.9% , Dutch 1.2% etc.


The Therapeutic Goods Administration (TGA) is the unit of the Australian government’s Department of Health and Aging that oversees medical device regulation in Australia.

Before selling any medical devices in Australia, they must first be included in the Australian Register of Therapeutic Goods (ARTG) which is regulated by the Australian Therapeutic Goods Administration (TGA) and be registered as well.

The registering pathway for medical devices with the TGA depends on their risk classification compliance with quality, safety and performance principles; compliance with regulatory controls for manufacturing processes; listing in the Australian Register of Therapeutic Goods; and post-market vigilance programs. For more information, check the TGA website at :

Devices that have already earned CE certification from European Notified Bodies can be easily substantiate conformity to TGA requirements. Manufacturers must also provide Declarations of Conformity to the Australian Regulations to register with the TGA.